Barry H. Boise

Barry represents clients ranging from multinational companies to early-stage start-ups in the health sciences and chemical manufacturing sectors. He helps clients to effectively confront risks such as multidistrict litigation, attorney general investigations, and other civil and criminal actions involving health care fraud and abuse. Barry also advises clients on the regulatory, compliance, and potential litigation risks as they launch new products and services and utilize emerging technologies, such as artificial intelligence.

Barry has significant experience in most state and federal courts throughout the U.S. and defends several of the largest global pharmaceutical and medical device companies in cases involving product liability and tort claims. With experience handling multiple litigations in Philadelphia County, he serves as lead counsel in a mass tort litigation and as a liaison counsel in a matter in the Philadelphia Mass Tort Program.

Barry is a frequent writer and speaker on matters affecting the life sciences industry, including litigation prevention, regulatory compliance, and settlement strategies. He is also a regular contributor to Regulatory Oversight, the firm’s podcast that discusses the latest regulatory developments. Barry is an active member of several organizations dedicated to the causes of his clients, including the Defense Research Institute and Lawyers for Civil Justice. He also is a fellow of the American Bar Foundation.

Barry is passionate about helping cancer patients, and is a founding Board member of Ride Hard Breathe Easy, a nonprofit dedicated to ending the suffering and stigma of lung cancer patients. Through biking and other events, Ride Hard funds innovation and assists lung cancer patients with the most basic needs that interfere with proper care and treatment.

• Defended pharmaceutical and medical device companies as national and trial counsel in products liability, consumer fraud, and class actions filed in multidistrict litigation, state court coordinated proceedings, and individual cases throughout the U.S.
• Defended a multinational chemical company against allegations of its agricultural products causing adverse health effects.
• Defended multiple, high-profile actions brought by state attorneys general against pharmaceutical and medical device companies, alleging Medicaid fraud, unfair trade practices, and consumer protection violations.
• Defended pharmaceutical companies in lawsuits brought by governmental and private insurers.
• Counseled and defended a social media company in attorney general investigations.
• Represented pharmaceutical manufacturers in resolving federal NAMFCU and multistate attorneys general investigations concerning sales, marketing, and manufacturing practices.
• Counseled and defended companies concerning claims that arise from clinical trial adverse events.
• Represented a technology company facing state attorney general, FTC, HHS, and other investigations and litigation involving a data breach.
• Counseled companies regarding FDA, FTC, and HIPAA risks in the development and promotion of mobile medical applications.
• Conducted internal investigations and risk assessments for pharmaceutical company compliance with federal health care laws.
• Counseled companies launching new products concerning regulatory, competitive, and litigation risks.
• Defended a large hospital and physician network as lead litigation counsel in payment disputes with Medicaid and commercial payors.
• Defended a physician practice group responding to an OIG and U.S. Department of Justice Medicare billing investigation; negotiated settlement and corporate integrity agreement, and managed press relations.
• Counseled pharmaceutical companies in the negotiation and implementation of in-licensing, co-promotion, and contract research organization arrangements.
• Counseled pharmaceutical and medical device companies regarding regulatory and litigation risks presented by pharmacogenomics or personalized medicine, and the launch of new products and emerging technologies in the mobile medical applications and health IT fields.
• Represented a pharmaceutical company in litigation involving adverse events in clinical trials.
• Counseled medical device and pharmaceutical companies concerning product labeling, instructions for use, and other health care interactions.

• Chambers USA: Product Liability & Mass Torts, USA Nationwide (2024-2025) and Litigation: Product Liability, Pennsylvania (2025)
• Best Lawyers in America®: Philadelphia “Lawyer of the Year” for Product Liability Litigation – Defendants (2026)
• Best Lawyers in America®: Product Liability Litigation – Defendants (2016-2026)
• LMG Life Sciences: Life Sciences Star, Product Liability (2021-2022)
• The Legal 500 United States (2014, 2020-2024)